Cost is one of the most common practical barriers people ask about before starting buprenorphine — here’s a realistic picture.
Without insurance: Generic buprenorphine-naloxone typically costs roughly $100–450 per month depending on the pharmacy and specific product; brand-name Suboxone tends to cost more than the generic equivalent. Discount programs (like manufacturer coupons or pharmacy discount cards) can lower this significantly for some people.
With private insurance: Under federal parity law (MHPAEA), your plan is required to cover this comparably to other medical benefits — your specific copay depends on your plan’s formulary and deductible. insurance appeal builder tool if coverage is denied
With Medicaid: Buprenorphine is covered in every state’s Medicaid program, often with minimal or no copay — confirm your specific prescriber and pharmacy accept Medicaid.
Injectable formulations (Sublocade, Brixadi): These carry significantly higher list prices than daily sublingual formulations — insurance coverage is common but prior authorization may be required; ask your prescriber’s office about this specifically before assuming cost either way.
If cost is still a barrier: Federally Qualified Health Centers offer sliding-scale buprenorphine treatment regardless of insurance status, and manufacturer patient assistance programs exist for some formulations — worth asking about directly rather than assuming there’s no affordable path.
full cost estimator tool for a broader comparison across treatment types
Medically reviewed by [pending]. Sources: SingleCare and Eleanor Health cost data (2026), Medicaid coverage policy, MHPAEA.